Factor 5 deficiency (or coagulation factor V deficiency) is a hereditary disorder characterized by a decrease in the level of factor V, an important component of hemostasis. This leads to an increased risk of thrombus formation and the development of venous thrombophilia. The pathology is caused by mutations in the F5 gene, located on chromosome 1, which is responsible for the synthesis of factor V in the liver. Factor V deficiency can manifest itself in both severe and mild clinical variants, but in any case, it requires a careful and timely diagnostic approach, as well as individualized treatment.
History of the disease and interesting historical facts
Factor V deficiency was first described in 1948 when researchers learned of a number of cases of thrombosis associated with abnormal levels of factor V. Since then, the disease has been the subject of various studies that have revealed its hereditary aspects. In the 1980s, mutations in the gene encoding factor V were identified as the main cause of the disease, opening up new horizons in understanding the pathogenesis and treatment options. Of particular interest is the fact that patients with severe factor V deficiency show features similar to other hereditary coagulopathies, which makes diagnosis somewhat challenging.
Epidemiology
The epidemiology of factor V deficiency shows variations in prevalence among populations. The incidence is estimated to be between 1:100,000 and 1:1,000,000 in the general population, but may be significantly higher in certain ethnic groups, such as Scandinavians. Studies have shown that women are slightly more likely to be affected than men. There has been an increase in the incidence of hypercoagulability in recent decades, which may be due to improved diagnostic techniques and increased awareness among the medical community.
Genetic predisposition to this disease
Factor V deficiency is hereditary, occurring in an autosomal recessive manner. The main gene involved in the development of the disease is F5, which codes for the factor V protein. Mutations in this gene can manifest themselves in various forms - from small point changes to large deletions or insertions that affect the synthesis and function of factor V. According to research, more than 80 mutations in the F5 gene have been associated with clinically diagnosed factor V deficiency, which demonstrated significant genetic heterogeneity of this condition.
Risk factors for the development of this disease
There are several risk factors that contribute to the development of factor V deficiency, which can be classified as follows:
- Genetic factors - the presence of similar cases in the family, especially among close relatives.
- Physical factors - There is some evidence of a link between factor V deficiency and physical activity, with high levels of physical activity possibly aggravating the condition.
- Chemical factors - some medications, such as anticoagulants, can affect factor V levels and increase the risk of blood clots.
- Comorbidities such as hypertension and obesity can worsen the course of the disease.
- External factors such as smoking and alcohol abuse can also have a negative impact on the patient's condition.
Diagnosis of this disease
Diagnosis of factor V deficiency is multi-level and includes the following elements:
- Major symptoms may include failure to stop bleeding normally, hematomas, blood clots, and liver dysfunction.
- Laboratory tests traditionally include determination of activated partial thromboplastin time (aPTT) and quantitative determination of factor V.
- Radiologic examinations can be used to visualize venous thrombosis, especially in the lower extremities.
- Other diagnostic tests include molecular genetic testing to detect mutations in the F5 gene.
- Differential diagnosis is important to exclude other coagulopathies such as von Willebrand disease and factor VIII deficiency.
Treatment
Treatment for factor V deficiency depends on the severity of the condition and includes the following aspects:
- General treatment may include supportive care to prevent blood clots, such as the use of compression stockings.
- Pharmacological treatment includes the use of anticoagulants such as warfarin or newer oral anticoagulants to reduce the risk of blood clots.
- Surgical treatment is used in extreme cases when thrombus formation occurs, requiring surgical intervention.
- Other treatments may include the administration of preparations containing factor V concentrates, but their use is limited.
List of medications used to treat this disease
The main drugs used to treat factor V deficiency include:
- Warfarin is an anticoagulant that intensifies the anticoagulant effect.
- Rivaroxaban is a new oral anticoagulant with a more predictable anticoagulant effect.
- Enoxaparin is a low molecular weight heparin that is used to prevent venous thromboembolism.
- Coagulation factors - preparations containing pure factor V are rarely used due to their high cost and limited availability.
Disease monitoring
Monitoring factor V deficiency requires a modified approach depending on the patient's clinical status:
- Control stages of factor V level measurement should be carried out every 3-6 months during stable disease course.
- The prognosis depends on the severity of the disorder. In mild cases, a normal life can be expected, while severe cases require constant monitoring and treatment.
- Complications may include blood clots, making regular monitoring essential to prevent serious consequences.
Age-related features of the disease
Factor V deficiency has its own age-related characteristics:
- In newborns, the disease may be detected based on obvious symptoms such as sudden bleeding.
- In childhood, a mild form with minimal manifestations may be observed, but in adolescence, the risk of thrombosis increases.
- In older people, the disease may manifest itself more aggressively due to the presence of concomitant pathologies that increase the risk of thrombosis.
Questions and Answers
- What are the main symptoms of factor V deficiency? The main symptoms include frequent nosebleeds, hematomas from even minor trauma, and temporary cessation of bleeding. Some patients may develop blood clots.
- How is factor V deficiency diagnosed? Diagnosis includes clinical examination, laboratory tests including activated partial thromboplastin test and molecular genetic tests.
- What is the treatment for factor V deficiency? Treatment may include anticoagulant therapy, use of compression stockings and, in rare cases, surgery to remove blood clots.
- What are the risks associated with this disease? Risks include the formation of blood clots, which can lead to venous thromboembolism and other serious complications including thrombophlebitis and pulmonary embolism.
- Do patients with factor V deficiency need to be seen by specialists? Yes, regular monitoring by a hematologist is essential to monitor factor V levels and prevent blood clots.
Dr. Oleg Korzhikov recommends the following: “When diagnosed with factor V deficiency, it is important to be attentive and always stay in touch with your doctor. Regular check-ups and following appointments will help you avoid serious complications and improve your quality of life. Don’t forget about moderate physical activity and diet — this can be no less important for your treatment than medication. Also, discuss with your doctor the use of vitamins and supplements that can support your overall health.”
